Global and Region Adoptive Cellular Immunotherapy Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.

    The report details the trend, potential and market size of Adoptive Cellular Immunotherapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Adoptive Cellular Immunotherapymarket, defines the market attractiveness level of Adoptive Cellular Immunotherapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Adoptive Cellular Immunotherapy industry, describes the types of Adoptive Cellular Immunotherapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Adoptive Cellular Immunotherapy market and the development prospects and opportunities of Adoptive Cellular Immunotherapy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Adoptive Cellular Immunotherapy market in Chapter 13.

    By Player:

    • Company 1

    • Company 2

    • Company 3

    • Company 4

    • Company 5

    • Company 6

    • Company 7

    • Company 8

    • Company 9

    • Company 10

    By Type:

    • TIL

    • LAK

    • CAR-T

    • TCR-T

    • CIK

    • NK

    • DC

    • Other

    By End-User:

    • Hospital

    • Cancer Hospital

    • Centers for Disease Control and Prevention

    • Rehabilitation Center

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Adoptive Cellular Immunotherapy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Adoptive Cellular Immunotherapy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Adoptive Cellular Immunotherapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Adoptive Cellular Immunotherapy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Adoptive Cellular Immunotherapy Market Analysis and Outlook to 2022

    • 7.1 Global Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.2 United States Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.3 Europe Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.4 China Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.5 Japan Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.6 India Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.7 South Korea Adoptive Cellular Immunotherapy Consumption (2017-2022)

    8 Region and Country-wise Adoptive Cellular Immunotherapy Market Analysis and Outlook to 2028

    • 8.1 Global Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.2 United States Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.3 Europe Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.4 China Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.5 Japan Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.6 India Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.7 South Korea Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    9 Global Adoptive Cellular Immunotherapy Market Outlook by Types and Applications to 2022

    • 9.1 Global Adoptive Cellular Immunotherapy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global TIL Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global LAK Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CAR-T Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global TCR-T Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global CIK Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global NK Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global DC Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Adoptive Cellular Immunotherapy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Centers for Disease Control and Prevention Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Rehabilitation Center Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Adoptive Cellular Immunotherapy Market Outlook by Types and Applications to 2028

    • 10.1 Global Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global TIL Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global LAK Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global CAR-T Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global TCR-T Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global CIK Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global NK Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global DC Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cancer Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Centers for Disease Control and Prevention Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Rehabilitation Center Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Adoptive Cellular Immunotherapy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Adoptive Cellular Immunotherapy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Adoptive Cellular Immunotherapy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Adoptive Cellular Immunotherapy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Adoptive Cellular Immunotherapy Market Competitive Analysis

    • 14.1 Company 1

      • 14.1.1 Company 1 Company Details

      • 14.1.2 Company 1 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Company 1 Adoptive Cellular Immunotherapy Product and Service

    • 14.2 Company 2

      • 14.2.1 Company 2 Company Details

      • 14.2.2 Company 2 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Company 2 Adoptive Cellular Immunotherapy Product and Service

    • 14.3 Company 3

      • 14.3.1 Company 3 Company Details

      • 14.3.2 Company 3 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Company 3 Adoptive Cellular Immunotherapy Product and Service

    • 14.4 Company 4

      • 14.4.1 Company 4 Company Details

      • 14.4.2 Company 4 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Company 4 Adoptive Cellular Immunotherapy Product and Service

    • 14.5 Company 5

      • 14.5.1 Company 5 Company Details

      • 14.5.2 Company 5 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Company 5 Adoptive Cellular Immunotherapy Product and Service

    • 14.6 Company 6

      • 14.6.1 Company 6 Company Details

      • 14.6.2 Company 6 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Company 6 Adoptive Cellular Immunotherapy Product and Service

    • 14.7 Company 7

      • 14.7.1 Company 7 Company Details

      • 14.7.2 Company 7 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Company 7 Adoptive Cellular Immunotherapy Product and Service

    • 14.8 Company 8

      • 14.8.1 Company 8 Company Details

      • 14.8.2 Company 8 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Company 8 Adoptive Cellular Immunotherapy Product and Service

    • 14.9 Company 9

      • 14.9.1 Company 9 Company Details

      • 14.9.2 Company 9 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Company 9 Adoptive Cellular Immunotherapy Product and Service

    • 14.10 Company 10

      • 14.10.1 Company 10 Company Details

      • 14.10.2 Company 10 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Company 10 Adoptive Cellular Immunotherapy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Adoptive Cellular Immunotherapy

    • Figure Adoptive Cellular Immunotherapy Picture

    • Table Global Adoptive Cellular Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Adoptive Cellular Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Adoptive Cellular Immunotherapy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Adoptive Cellular Immunotherapy Consumption by Country (2017-2022)

    • Figure United States Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Table Europe Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure China Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Japan Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure India Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Adoptive Cellular Immunotherapy Consumption Forecast by Country (2022-2028)

    • Figure United States Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global TIL Consumption and Growth Rate (2017-2022)

    • Figure Global LAK Consumption and Growth Rate (2017-2022)

    • Figure Global CAR-T Consumption and Growth Rate (2017-2022)

    • Figure Global TCR-T Consumption and Growth Rate (2017-2022)

    • Figure Global CIK Consumption and Growth Rate (2017-2022)

    • Figure Global NK Consumption and Growth Rate (2017-2022)

    • Figure Global DC Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Centers for Disease Control and Prevention Consumption and Growth Rate (2017-2022)

    • Figure Global Rehabilitation Center Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global TIL Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global LAK Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CAR-T Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global TCR-T Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CIK Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NK Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DC Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Centers for Disease Control and Prevention Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rehabilitation Center Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Adoptive Cellular Immunotherapy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Adoptive Cellular Immunotherapy Export by Region (Top 5 Countries) (2017-2028)

    • Table Company 1 (Foundation Year, Company Profile and etc.)

    • Table Company 1 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 1 Adoptive Cellular Immunotherapy Product and Service

    • Table Company 2 (Foundation Year, Company Profile and etc.)

    • Table Company 2 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 2 Adoptive Cellular Immunotherapy Product and Service

    • Table Company 3 (Foundation Year, Company Profile and etc.)

    • Table Company 3 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 3 Adoptive Cellular Immunotherapy Product and Service

    • Table Company 4 (Foundation Year, Company Profile and etc.)

    • Table Company 4 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 4 Adoptive Cellular Immunotherapy Product and Service

    • Table Company 5 (Foundation Year, Company Profile and etc.)

    • Table Company 5 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 5 Adoptive Cellular Immunotherapy Product and Service

    • Table Company 6 (Foundation Year, Company Profile and etc.)

    • Table Company 6 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 6 Adoptive Cellular Immunotherapy Product and Service

    • Table Company 7 (Foundation Year, Company Profile and etc.)

    • Table Company 7 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 7 Adoptive Cellular Immunotherapy Product and Service

    • Table Company 8 (Foundation Year, Company Profile and etc.)

    • Table Company 8 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 8 Adoptive Cellular Immunotherapy Product and Service

    • Table Company 9 (Foundation Year, Company Profile and etc.)

    • Table Company 9 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 9 Adoptive Cellular Immunotherapy Product and Service

    • Table Company 10 (Foundation Year, Company Profile and etc.)

    • Table Company 10 Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 10 Adoptive Cellular Immunotherapy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.